Carl W. Hull

Chief Executive Officer & Partner at Maravai Life Sciences, Inc.

Carl W. Hull

Carl W. Hull

Chief Executive Officer & Partner at Maravai Life Sciences, Inc.

Overview
Career Highlights

Maravai Life Sciences, Inc.
Gen-Probe, Inc.
Applied Imaging Corp.

RelSci Relationships

674

Number of Boards

8

Birthday

1958

Age

61

Relationships
RelSci Relationships are individuals Carl W. Hull likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Trustee at San Diego Regional Economic Development Corporation

Relationship likelihood: Strong

Co-Founder at Neurelis, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at BIOCOM

Relationship likelihood: Strong

President & Partner at Maravai Life Sciences, Inc.

Relationship likelihood: Strong

Founder at XIFIN, Inc.

Relationship likelihood: Strong

Co-Founder at Sorrento Associates, Inc.

Relationship likelihood: Strong

Managing Director at GTCR LLC

Relationship likelihood: Strong

Vice President & Chief Financial Officer at Maravai Life Sciences, Inc.

Relationship likelihood: Strong

Director & Co-Founder at BIOCOM

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Banyan Biomarkers, Inc.

Relationship likelihood: Strong

Paths to Carl W. Hull
Potential Connections via
Relationship Science
You
Carl W. Hull
Chief Executive Officer & Partner at Maravai Life Sciences, Inc.
Education
BA in Political Science & International Relations

The Johns Hopkins University opened in 1876, with the inauguration of its first president, Daniel Coit Gilman. "What are we aiming at?" Gilman asked in his installation address. "The encouragement of research ... and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell." The mission laid out by Gilman remains the university's mission today, summed up in a simple but powerful restatement of Gilman's own words: "Knowledge for the world." What Gilman created was a research university, dedicated to advancing both students' knowledge and the state of human knowledge through research and scholarship. Gilman believed that teaching and research are interdependent, that success in one depends on success in the other. A modern university, he believed, must do both well. The realization of Gilman's philosophy at Johns Hopkins, and at other institutions that later attracted Johns Hopkins-trained scholars, revolutionized higher education in America, leading to the research university system as it exists today. After more than 130 years, Johns Hopkins remains a world leader in both teaching and research. Eminent professors mentor top students in the arts and music, the humanities, the social and natural sciences, engineering, international studies, education, business and the health professions. Those same faculty members, and their research colleagues at the university's Applied Physics Laboratory, have each year since 1979 won Johns Hopkins more federal research and development funding than any other university. The university has nine academic divisions and campuses throughout the Baltimore-Washington area. The Krieger School of Arts and Sciences, the Whiting School of Engineering, the School of Education and the Carey Business School are based at the Homewood campus in northern Baltimore. The schools of Medicine, Public Health, and Nursing share a campus in east Baltimore with The Johns Hopkins Hospital. The Peabody Institute, a leading professional school of music, is located on Mount Vernon Place in downtown Baltimore. The Paul H. Nitze School of Advanced International Studies is located in Washington's Dupont Circle area. The Applied Physics Laboratory is a division of the university co-equal to the nine schools, but with a non-academic, research-based mission. APL, located between Baltimore and Washington, supports national security and also pursues space science, exploration of the Solar System and other civilian research and development. Johns Hopkins also has a campus near Rockville in Montgomery County, Md., and has academic facilities in Nanjing, China, and in Bologna, Italy. It maintains a network of continuing education facilities throughout the Baltimore-Washington region, including centers in downtown Baltimore, in downtown Washington and in Columbia. When considered in partnership with its sister institution, the Johns Hopkins Hospital and Health System, the university is Maryland's largest employer and contributes more than $10 billion a year to the state's economy

MBA

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

Unknown

The University of Chicago's Office of Investments (COI) is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. COI oversees the broad investment strategy and provides input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.COI's approach seeks to evaluate the investment strategy as an integrated part of the operating plans of the University rather than in isolation and focuses the the University's overall success, not investment returns. The endowment is well-diversified across a variety of asset classes, including global stocks and bonds, real estate, natural resources, private equity, absolute return strategies and protection (tail-hedging strategies). Asset class exposure is achieved primarily by selecting and engaging external managers. COI manages the global macro and the overlay portfolio to ensure that the portfolio's overall positioning is compliance with the endowment's investment guidelines.COI's strategies for investing in the public markets include: Absolute Return, Private Debt, Fixed Income and Credit. and Global Equities.COI's real assets team invests globally in real estate and natural resources using outside managers. The real estate portfolio invests globally in value-added and opportunistic strategies using both private partnerships and public vehicles. The natural resources portfolio invests globally in strategies that include, but are not limited to: oil and gas exploration & production; power generation; infrastructure; timber; mining and minerals; and agriculture.

Career History
Chief Executive Officer & Partner
2014 - Current

Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 2014 and is headquartered in San Diego, CA.

Senior Vice President & General Manager, Diagnostics Line of Business
2012 - 2013

Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health

Chairman, President & Chief Executive Officer
2007 - 2012

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

Boards & Committees
Independent Director
2015 - Current
Director
Current

XIFIN, Inc. develops financial management software. Its cloud-based health economics optimization platform enables end to end connectivity from patient to payment, linking together the stakeholders in the delivery of healthcare, and optimizing for the business and patient outcomes. The company was founded by Lâle White in 1997 and is headquartered in San Diego, CA.

Director
Current

AdvaMedDx is the trade association representing the world’s leading diagnostics manufacturers in the United States

Member, Board of Directors
Current

Founded in 1989 and headquartered in San Diego, AIS provides tailored data center and cloud service solutions to companies that require the best in security, compliance, connectivity, and customer service. AIS manages all aspects of IT infrastructure so that customers can focus on their core business.

Chairman
Prior

CHI was founded in 1993 as an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community.

Director
Tenure Unconfirmed

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Carl W. Hull. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Carl W. Hull's profile does not indicate a business or promotional relationship of any kind between RelSci and Carl W. Hull.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/carl-w-hull-3363578
  • https://relationshipscience.com/person/carl-w-hull-3363578